THE DISCOVERY PROCESS

The process of discovering new antibiotics involves a wide range of bacterial cell targets, antibacterial agents and technical approaches. Here is an overview of these elements.

 

To find researchers in each of these areas, please visit the Registry page. You will need to be a member to access this page.

Bacteria cellular target and antibacterial agents

PABA

DHF

THF

-Sulfonamides

-Trimethoprim

-Bacteriocins

-Isoniazid

-Lipopeptides

-Macrolides

-Microcins

-Nisin

-Polypeptides

-Aminocoumarins

-Aminonucleosides

-Ansamycins

-Antitubercular agents

-Epothilones

-(Fluoro)quinolones

-Aminoglycosides

-Amphenicols

-Glycylcycline

-Lincosamides

-Macrolides

-Mupirocin

-Nitrofurans

-Oxazolidinones

-Pleuromutilin

-Puromycin

-Streptogramins

-Tetracyclines

-Tigecycline

beta-lactams:

-Carbapenems

-Cephalosporins

-Monobactams

-Penicillins

-Alafosfalin

-Cycloserine

-Fosfomycin

-Glycopeptides

-Polypeptides

Source of Agent

Discovery Process no labels copy copy (4

Hit Discovery

Development Pipeline

Click on the blue boxes to expand

Analytical Methods

Legal

Medicinal

Chemistry

In Vitro

Studies

In Vivo

Studies

Clinical

Trials

© 2020 ABX

Figures created with BioRender.com